GenMark Diagnostics to Present at the 2017 J.P. Morgan Healthcare Conference
December 28 2016 - 4:05PM
Business Wire
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems, will
present at the 2017 J.P. Morgan Healthcare Conference to be held at
the Westin St. Francis Hotel in San Francisco, California, on
Wednesday, January 11, 2017. The presentation will be delivered by
Hany Massarany, President and Chief Executive Officer, and is
scheduled to begin at 1:30 pm Pacific Time. The presentation will
be made available at http://ir.genmarkdx.com/.
ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of
automated, multiplex molecular diagnostic testing systems that
detect and measure DNA and RNA targets to diagnose disease and
optimize patient treatment. Utilizing GenMark's proprietary
eSensor® detection technology, GenMark's eSensor
XT-8® system is designed to support a broad range of molecular
diagnostic tests with a compact, easy-to-use workstation and
self-contained, disposable test cartridges. The eSensor detection
technology is also incorporated into GenMark's sample-to-answer
system, ePlex®. For more information,
visit www.genmarkdx.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161228005001/en/
GenMark Diagnostics, Inc.Hany MassaranyPresident, Chief
Executive Officer760-448-4325
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Mar 2024 to Apr 2024
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Apr 2023 to Apr 2024